Teniposide Injection bulk supplier for pharma manufacturers

Teniposide Injection 50 mg/10 mL (5 mg/mL) Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/10 mL (5 mg/mL)

Reference Brands: Vumon.(US & EU)

Teniposide Injection (Vumon) is an oncology drug used to treat acute lymphoblastic leukemia (ALL) and neuroblastoma. Available in the U.S. and EU, it is supplied as 50 mg/10 mL (5 mg/mL) for intravenous infusion. Teniposide works by inhibiting topoisomerase II, preventing cancer cell division. Administered in hospital settings, it is part of chemotherapy regimens and requires careful handling due to potential side effects.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Teniposide Injection (Vumon) is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL) and neuroblastoma. Available in the U.S. and EU, Teniposide is typically supplied as 50 mg/10 mL (5 mg/mL) for intravenous infusion. As a topoisomerase II inhibitor, it interferes with DNA replication in cancer cells, preventing their division. This injectable formulation is essential in multi-drug chemotherapy regimens and is administered under the supervision of healthcare professionals in clinical settings. It requires careful handling due to potential side effects, including bone marrow suppression and liver toxicity, making it suitable for B2B pharmaceutical distribution in oncology.

Teniposide Injection — third party manufacturing & bulk supply

Teniposide Injection 50 mg/10 mL (5 mg/mL) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Teniposide Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Teniposide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Teniposide Injection →

Back to Listing

Frequently Asked Questions

Teniposide Injection is listed as Injection in 50 mg/10 mL (5 mg/mL). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Teniposide Injection is referenced against Vumon.(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.